A team of researchers from the University of Maryland School of Maryland’s Institute of Human Virology published new findings that emphasize the crucial role of the urinary and genital tract microbiota in adverse pregnancy outcomes and genomic instability that originate in the womb during fetal development.
The recent public health emergency declarations in New York and London due to polio infections and detection of the virus in these cities’ wastewater strongly indicate that polio is no longer close to being eradicated. Now, four members of the Global Virus Network (GVN) proposed changes in global polio eradication strategy to get the world back on track to one day eliminating polio’s threat.
A recent study performed in Zambia by University of Maryland School of Medicine’s (UMSOM) Institute of Human Virology researchers found that high uptake of HIV preventative medicine, known as pre-exposure prophylaxis (PrEP), is possible in prison populations with adequate resources and support from the criminal justice health system.
A new study involving hospitalized women in 6 African countries from the University of Maryland School of Medicine’s Institute of Human Virology showed that pregnant women with SARS-CoV-2 had 2X the risk of being admitted to the ICU and 4X the risk of dying than pregnant women who didn't have COVID-19.
The American Society for Clinical Investigation (ASCI) elected Mohammad Sajadi, MD, Professor of Medicine in the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) as a 2022 member.
University of Maryland School of Medicine (UMSOM)’s Institute of Human Virology (IHV) researchers received funding from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) for $2.7 million to study genetic changes in two genes from the HIV-1 virus that may make it resistant to antiretroviral therapy.
The award entitled, “Integrated Network of Scholars in Global Health Research Training (INSIGHT)” will expand global health research across sub-Saharan Africa, South Asia, Latin America, and the Caribbean by providing one-year mentored research training to U.S. and lower-middle income country scholars.
University of Maryland School of Medicine’s Institute of Human Virology contributes to Global Virus Network studies suggesting that the oral polio vaccine can protect people in developing nations that do not yet have access to COVID vaccines
Robert Gallo, MD, was awarded the Distinguished Alumni Award by the University of Chicago Medical & Biological Sciences Alumni Association (UChicago MBSAA) for his lifetime achievements.
The University of Maryland School of Medicine’s Institute of Human Virology researchers played a collaborative role in last month’s successful transplant of a genetically-modified pig heart into a patient with terminal heart disease by creating pathogen surveillance strategies and developing an infection prevention strategy for this unprecedent significant medical advancement.
The Institute of Human Virology at the University of Maryland School of Medicine and MitoPower LLC were awarded an Small Business Innovation Research grant of $6.5 million from the NIH’s National Institute on Alcohol Abuse and Alcoholism to develop a treatment for alcoholic liver disease-associated hepatorenal syndrome.
Researchers at the University of Maryland School of Medicine (UMSOM)’s Institute of Human Virology (IHV), a Global Virus Network (GVN) Center of Excellence, have received $6.5 million from the U.S. National Institutes of Health (NIH) to streamline big data collection in Nigeria and South Africa in addressing public health needs of the COVID-19 and HIV pandemics.
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine congratulates Treasurer Nancy Kopp on her five decades of public service, including since 2002, as the Maryland State Treasurer.
The Coalition for Epidemic Preparedness Innovations (CEPI) announced that Alash'le Abimiku, PhD, Professor of Medicine of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, will join their Scientific Advisory Committee for three-years.
Institute of Human Virology at the University of Maryland School of Maryland scientists, who are also members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in 35 countries, and colleagues today published a perspective proposing that live attenuated vaccines (LAVs), such as those for tuberculosis, measles, and polio, may induce protective innate immunity that mitigate other infectious diseases, triggering the human body’s natural emergency response to infections including COVID-19 as well as future pandemic threats.
The Institute of Human Virology at the University of Maryland School of Medicine mourns the passing of John Martin, PhD., a leader in supporting access to life-saving anti-HIV medications that although still under patent were made widely and affordably available to millions infected with HIV.
Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, was awarded Italy’s “Magna Graecia International Prize,” an award created in 1997 by the Magna Graecia Foundation that is bestowed to the most influential Italians and Italians of origin who have embodied and symbolized, in the most diverse sectors, the best qualities of Italy by extending Italian culture beyond national borders.
Shyam Kottilil, MBBS, PhD, professor of medicine at the University of Maryland School of Medicine (UMSOM), and Director of UMSOM’s Institute of Human Virology (IHV) Division of Clinical Care and Research, has been awarded Mastership in the American College of Physicians (ACP), the national organization of internists.
Robert C. Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine at the University of Maryland School of Medicine (UMSOM) and Co-Founder & Director of the UMSOM’s Institute of Human Virology (IHV), announced today that a team of leading scientists in human immunology, virology and stem cell biology, led by Lishan Su, PhD joined IHV on October 1 with academic appointments in the UMSOM Department of Pharmacology. As part of the Maryland E-Nnovation Initiative Fund (MEIF) to recruit top research faculty and a donation to IHV from the Charles Gordon Estate, Dr. Su has been named the Charles Gordon Smith Endowed Professor for HIV Research. Dr. Su will also head IHV’s Division of Virology, Pathogenesis and Cancer.
IHV announced today that Shenghan Lai, MD, MPH and Hong Lai, PhD, MPH, in addition to three staff members, and two more to add, have joined the Institute of Human Virology. The faculty began their positions on April 1 with Professor and Associate Professor academic appointments in the UMSOM’s Department of Epidemiology & Public Health.
The IHV and scientists from Rome, Italy announced studies showing the emergence of a SARS-CoV-2 viral strain with a deletion in a protein known as nsp1. These data, accepted for publication by the Journal of Translational Medicine, may indicate the emergence of a less pathogenic viral strain.
Researchers have developed an ultra-sensitive testing technique that has shown the ability to detect HIV infection earlier than all current methods. This new diagnostic approach combines two existing models and is 25 times more sensitive than the best technology currently available.
IHV develops new medication model for HIV/AIDS PATIENTS. Patients have coaches & partners to help them maintain rigorous schedule.
The Institute of Human Virology, a center of the University of Maryland Biotechnology Center and an affiliate of the University of Maryland School of Medicine, has become a designated site of the Adult AIDS Clinical Trials Group of the National Institutes of Health.
HIV-positive patients may be eligible for kidney transplants despite the fact they have the virus that causes AIDS. Due to therapeutic advances in HIV/AIDS care, those with the AIDS virus now can be considered as candidates for a multi-center five-year clinical trial evaluating the safety and effectiveness of this life-saving procedure in HIV-infected patients.
Annual conference to spotlight AIDS vaccine developments; reports on entry inhibitors.
In the wake of the Sept. 11 attacks and subsequent Anthrax scares, scientific researchers worldwide are working to expand the ability to rapidly assess what poses a terrorism threat to the public at large.
One of first scientific studies to evaluate psychological and spiritual effects on the immune system kicked off at the Institute of Human Virology.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right